Upgrade to SI Premium - Free Trial

Alkermes (ALKS) PT Lowered to $30 at Goldman Sachs

October 25, 2024 5:43 AM
Goldman Sachs analyst Chris Shibutani lowered the price target on Alkermes (NASDAQ: ALKS) to $30.00 (from $32.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles